News
Deals and Financings Shanghai Hasten Biopharma entered a $325 million agreement for greater China rights to a PCSK9 inhibitor aimed at lowering cholesterol from...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
Tessa RomeroJPMorgan Chase & Co, Research Division Welcome, everyone, to the 44th Annual JPMorgan Healthcare Conference. My name is Tessa Romero, and I’m one...
News
Franklin Resources, Inc. [NYSE:BEN] is a global investment management organization with subsidiaries operating as Franklin Templeton and serving clients in over 150 countries. Franklin...
News
This article was written by Follow With a background as a RN, I analyze healthcare-related stocks by evaluating clinical data, treatment guidelines, and market...
News
The pithy aphorism that “the best things in life are free,” while no doubt well-intentioned, is simply false. It’s slightly more accurate to suggest...
News
This article was written by I am the curator of the Dividend Champions list, a monthly publication of companies with a history of consistently...
News
The Fed may pass on raising rates this week, but that doesn’t mean they are done. Given the stronger-than-expected economic growth witnessed over the...
News
Investment Rundown The trajectory for Stepan Company (NYSE:SCL) has been a steady decline the last couple of months and I don’t think the price...
News
Investment Briefing AngioDynamics, Inc. (NASDAQ:ANGO) posted its fiscal ’23 numbers last month, with mixed results. On the one hand, divisional growth was strong in...
News
Background Known internally as ‘The Monthly Dividend Company,’ Realty Income Corporation (NYSE:O) is the largest single-client property landlord in the U.S., with 255.5 million...
News
The global growth outlook has improved in recent weeks despite concerning data trends out of China. The US and Europe are helping to improve...
News
Simplify Volatility Premium ETF (NYSEARCA:SVOL) is one of my favorite ETFs and I’ve covered it with a couple articles in the past. SVOL Can...
News
Investment Thesis Illinois Tool Works (NYSE:ITW) is well-positioned to deliver revenue growth and margin expansion. The company is seeing good demand for ~75% of...
